During the past decade, LTD Central University Clinic After Academic N. Kipshidze conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LTD Central University Clinic After Academic N. Kipshidze" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "UroGen Pharma Ltd." with 2 trials sponsored, "Basilea Pharmaceutica" with 1 trials sponsored and "BioAegis Therapeutics Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LTD Central University Clinic After Academic N. Kipshidze" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "LTD Central University Clinic After Academic N. Kipshidze" are "Ulcerative Colitis" (5 trials), "Bladder Cancer" (2 trials), "Urothelial Carcinoma" (2 trials), "Urothelial Carcinoma Bladder" (2 trials) and "Community-acquired Pneumonia" (1 trials). Many other conditions were trialed in "LTD Central University Clinic After Academic N. Kipshidze" in a lesser frequency.

Most popular intervention types in "LTD Central University Clinic After Academic N. Kipshidze" are "Drug" (10 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (4 trials), "UGN-102" (2 trials), "Ceftobiprole medocaril" (1 trials) and "Daptomycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "LTD Central University Clinic After Academic N. Kipshidze" are 10 trials for "All" genders.

Currently, there are NaN active trials in "LTD Central University Clinic After Academic N. Kipshidze". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in LTD Central University Clinic After Academic N. Kipshidze, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in LTD Central University Clinic After Academic N. Kipshidze, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

LTD Central University Clinic After Academic N. Kipshidze has several departments that took part in Clinical trials: "Ltd. M.Zodelava Hematology Centre" - 7 trials, "Institute of Clinical Cardiology Ltd" - 5 trials, "LTD Cancer Research Centre" - 4 trials, "National Center of Urology" - 4 trials, "Sarajishvili Institute of Neurology" - 6 trials, "Pediatric Surgery Center" - 2 trials, "LTD Gidmedi, Urology Department" - 2 trials, "V.Tsitlanadze Scientifically-Practical Rheumatology Center LTD" - 2 trials, "National Center for Diabetes Research LTD" - 2 trials